Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study — Hyunjean Jung (2019) | RDL Network
Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study
Article 2019 en
Authors
HJ
Hyunjean Jung
PY
Pil‐Sung Yang
JS
Jung‐Hoon Sung
Abstract
1 min read
Among all NVAF patients, 1.1% of patient has HCM. The risk of stroke in NVAF with HCM without any CHA<sub>2</sub>DS<sub>2</sub>-VASc stroke risk factors was similar to that of those patients without HCM with CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 3. Despite this, the actual use of OACs among NVAF patients with HCM was sub-optimal, relative to their high stroke risk.
Seung Yong Shin, Sang Jin Han, Jin Seok Kim, Sung Il Im, Jaemin Shim, Jinhee Ahn, Eun Mi Lee, Yae Min Park, Jun Hyung Kim, Professor Gregory Lip, Hong Euy Lim
Discussion(0)
No comments yet. Be the first to comment.